City

Kansas City (1)

Los Angeles (1)

Norfolk (1)

Phila (1)

San Francisco (1)

Condition

Flushing (5)

Alcohol-Related Disorders (1)

Aldehyde Dehydrogenase Deficiency (1)

Dyslipidemias (1)

Hypercholesterolemia (1)

Hyperlipidemias (1)

Overall Status

Completed (5)

Sign in for free

Phase

phase 4 (2)

early phase 1 (1)

n/a (1)

Sponsor

Eastern Virginia Medical School (1)

Patrick Moriarty, MD, FACP, FACC (1)

University of California, San Francisco (1)

University of Pennsylvania (1)

VA Greater Los Angeles Healthcare System (1)

Collaborator

Abbott (2)

Intervention

placebo (2)

apple pectin (1)

aspirin (1)

aspirin 325 mg (1)

brimonidine tartrate (1)

niacin and aspirin (1)

placebo vehicle gel (1)

psyllium (1)

quercetin (1)

Study Documents

Intervention Type

drug (4)

dietary supplement (2)

other (1)

Funder Type

Other (4)

U.S. Fed (1)

Study Type

Interventional (4)

Observational (1)

flushing

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Flushing, Alcohol-Related Disorders, Aldehyde Dehydrogenase Deficiency Trial in San Francisco (Brimonidine Tartrate, Placebo

Completed

Flushing
+2 more

Brimonidine Tartrate
Placebo Vehicle Gel

San Francisco, California

UC, San Francisco

Apr 30, 2020

Flushing, Hyperlipidemias, Dyslipidemias Trial in Los Angeles (Psyllium, Aspirin)

Completed

Flushing
+2 more

Psyllium
Aspirin

Los Angeles, California

VA West Los Angeles Medical Center

Dec 7, 2017

Flushing Trial in Phila (Quercetin, Placebo)

Completed

Flushing

Quercetin
Placebo

Phila, Pennsylvania
+1 more

Feb 19, 2015

Hypercholesterolemia, Flushing Trial in Kansas City (Apple pectin, Aspirin 325 mg, Placebo)

Completed

Hypercholesterolemia
Flushing

Apple pectin
+2 more

Kansas City, Kansas

University of Kansas Medical Center

May 22, 2014

Role of Prostaglandins on Niacin-Induced Flushing

Completed

Flushing

Niacin and aspirin

Norfolk, Virginia

Eastern Virgnia Medical School, Strelitz Diabetes Center

Mar 9, 2010